Expression of antibodies inside cells has been used successfully to ablate
protein function. This finding suggests that the technology should have an
impact on disease treatment and in functional genomics where proteins of un
known function are predicted from genomic sequences. A major hindrance is t
he paucity of antibodies that function in eukaryotic cells, presumably beca
use the antibodies fold incorrectly in the cytoplasm, To overcome this prob
lem, we have developed an in vivo assay for functional intracellular antibo
dies using a two-hybrid approach. In this assay, antibody, as single-chain
Fv (scFv) linked to a transcriptional transactivation domain, can interact
with a target antigen, linked to a LexA-DNA binding domain, and thereby act
ivate a reporter gene. We find that several characterized antibodies can bi
nd their target antigen in eukaryotic cells in this two-hybrid format, and
we have been able to isolate intracellular binders from among sets of scFv
that can bind antigen in vitro. Furthermore, we show a model selection in w
hich a single scFv was isolated from a mixture of half a million clones, in
dicating that this is a robust procedure that should facilitate capture of
antibody specificities from complex mixtures. The approach can provide the
basis for de novo selection of intracellular scFv from libraries, such as t
hose made from spleen RNA after immunization with antigen, for intracellula
r analysis of protein function based only on genomic or cDNA sequences.